I don't think the cap raise is as urgent as some people think. We had over $4m in cash at the end of last quarter. Can expect around $1m net loss this qtr. However, next qtr should pick up with the bulk of revenue expected then. We are still waiting on Malta update. They may even look at alternative options to a CR for Malta. If revenue keeps increasing, the cashburn will slow. Still significantly undervalued.
Ann: Definitive Supply Agreement Executed with HL Pharma, page-119
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.025(7.58%) |
Mkt cap ! $14.52M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 30.0¢ | $1.48K | 4.929K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11225 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 823 | 3 |
View Market Depth
| Last trade - 15.11pm 30/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |